featured
Brentuximab Vedotin With Chemotherapy for Stage III or IV Classical Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brentuximab Vedotin With Chemotherapy for Stage III or IV Classical Hodgkin Lymphoma (ECHELON-1): 5-Year Update of an International, Open-Label, Randomised, Phase 3 Trial
Lancet Haematol 2021 Jun 01;8(6)e410-e421, DJ Straus, M Długosz-Danecka, JM Connors, S Alekseev, Á Illés, M Picardi, E Lech-Maranda, T Feldman, P Smolewski, KJ Savage, NL Bartlett, J Walewski, R Ramchandren, PL Zinzani, M Hutchings, J Munoz, HJ Lee, WS Kim, R Advani, SM Ansell, A Younes, A Gallamini, R Liu, M Little, K Fenton, M Fanale, J RadfordFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.